Supporting cell & gene therapy innovation with continuous monitoring
In this webinar we welcome Dr. Shin Kawamata, CEO & President of Cyto-Facto Inc. Dr. Kawamata describes how Cyto-Facto uses the viewLinc continuous monitoring system in controlled environments to meet the growing need for reliable cell and gene therapy products and ensure compliance with strict GCTP regulations.